Profile
Peter Covitz worked as a Vice President-Professional Services at InforMax, Inc. He then worked as a Senior Vice President-Innovation at Nordion (Canada), Inc. and MDS Nordion, Inc. respectively.
Prior to that, he worked as a Manager at Incyte Pharmaceuticals, Inc. and Molecular Applications Group.
He also served as the COO-Center for Biomedical Informatics at the National Cancer Institute.
Dr. Covitz holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Colgate University.
Former positions of Peter Covitz
| Companies | Position | End |
|---|---|---|
| NORDION INC | Corporate Officer/Principal | - |
| Molecular Applications Group | Corporate Officer/Principal | - |
Incyte Pharmaceuticals, Inc.
 Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
InforMax, Inc.
 InforMax, Inc. Packaged SoftwareTechnology Services InforMax, Inc. develops software used in the analysis of genomic, proteomic, and other bio-molecular data. The company was founded by Alexander Titomirov and James E. Bernstein on May 1990 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Training of Peter Covitz
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Colgate University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MDS Nordion, Inc.
 MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Health Technology |
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
InforMax, Inc.
InforMax, Inc. Packaged SoftwareTechnology Services InforMax, Inc. develops software used in the analysis of genomic, proteomic, and other bio-molecular data. The company was founded by Alexander Titomirov and James E. Bernstein on May 1990 and is headquartered in Gaithersburg, MD. | Technology Services |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
| Molecular Applications Group |
- Stock Market
- Insiders
- Peter Covitz
